Eton Pharmaceuticals Inc
NASDAQ:ETON

Watchlist Manager
Eton Pharmaceuticals Inc Logo
Eton Pharmaceuticals Inc
NASDAQ:ETON
Watchlist
Price: 11.23 USD 4.47% Market Closed
Market Cap: 290.2m USD
Have any thoughts about
Eton Pharmaceuticals Inc?
Write Note

Relative Value

The Relative Value of one ETON stock under the Base Case scenario is 6.92 USD. Compared to the current market price of 11.23 USD, Eton Pharmaceuticals Inc is Overvalued by 38%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ETON Relative Value
Base Case
6.92 USD
Overvaluation 38%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
42
vs Industry
42
Median 3Y
3.9
Median 5Y
5.7
Industry
2.5
Forward
7.7
vs History
vs Industry
3
Median 3Y
-11.6
Median 5Y
-7.9
Industry
21.9
Forward
-62.9
vs History
4
vs Industry
27
Median 3Y
13.3
Median 5Y
-7
Industry
16.5
vs History
vs Industry
5
Median 3Y
-6.6
Median 5Y
-8.5
Industry
23.6
vs History
9
vs Industry
12
Median 3Y
6.5
Median 5Y
7.6
Industry
2.1
vs History
41
vs Industry
48
Median 3Y
3.3
Median 5Y
4.6
Industry
2.6
Forward
7.1
vs History
9
vs Industry
57
Median 3Y
4.6
Median 5Y
4.4
Industry
5.2
vs History
vs Industry
7
Median 3Y
-12.4
Median 5Y
-8.7
Industry
13.3
Forward
-176.4
vs History
vs Industry
2
Median 3Y
-10.4
Median 5Y
-7.6
Industry
16.6
Forward
-73.1
vs History
4
vs Industry
32
Median 3Y
10.8
Median 5Y
-6.4
Industry
15.6
vs History
vs Industry
19
Median 3Y
-6.3
Median 5Y
-7.4
Industry
19.1
vs History
42
vs Industry
15
Median 3Y
11
Median 5Y
13.4
Industry
1.9

Multiples Across Competitors

ETON Competitors Multiples
Eton Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Eton Pharmaceuticals Inc
NASDAQ:ETON
290.1m USD 8.4 -52.9 -64.9 -51.7
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
US
Eton Pharmaceuticals Inc
NASDAQ:ETON
Average P/E: 32.4
Negative Multiple: -52.9
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top